Fernando López-Calderón
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Epigenetics and DNA Methylation, Cancer-related molecular mechanisms research, Advanced Breast Cancer Therapies, FOXO transcription factor regulation
Most-Cited Works
- → BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer(2017)217 cited
- → Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression(2019)187 cited
- → EZH2 in Bladder Cancer, a Promising Therapeutic Target(2015)64 cited
- → Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer(2015)62 cited
- → New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells(2020)61 cited
- → CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status(2018)57 cited
- → The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo(2021)50 cited
- → A Polycomb-mir200 loop regulates clinical outcome in bladder cancer(2015)45 cited
- → Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer(2017)14 cited
- → Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor(2020)9 cited